InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Brown James F, Director. Director active across 1 company, notably Bellicum Pharmaceuticals, INC. Aggregated, 1 disclosures have been logged. Activity tracked since 4 January 2022. The latest transaction was disclosed on 4 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
James F. Brown is a Board Member at Bellicum Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and developing its strategy. Bellicum Pharmaceuticals, Inc. is a biopharmaceutical company focused on innovation in cancer treatment.